Acromegaly pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
=== Pathogenesis === | === Pathogenesis === | ||
*It is thought that acromegaly caused by pituitary adenomas either microadenomas or macroadenomas. | *It is thought that acromegaly caused by GH secreting pituitary adenomas either microadenomas or macroadenomas. | ||
*Normally, the growth hormone is secreted and stored in the anterior pituitary gland particularly in the somatotroph cells. Growth hormone secretion is affected by several factors. Growth hormone is stimulated by ghrelin and growth hormone releasing hormone. Somatostatin inhibits the growth hormone secretion.<ref name="pmid26873451">{{cite journal| author=Dineen R, Stewart PM, Sherlock M| title=Acromegaly. | journal=QJM | year= 2016 | volume= | issue= | pages= | pmid=26873451 | doi=10.1093/qjmed/hcw004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26873451 }} </ref> | *Normally, the growth hormone is secreted and stored in the anterior pituitary gland particularly in the somatotroph cells. Growth hormone secretion is affected by several factors. Growth hormone is stimulated by ghrelin and growth hormone releasing hormone. Somatostatin inhibits the growth hormone secretion.<ref name="pmid26873451">{{cite journal| author=Dineen R, Stewart PM, Sherlock M| title=Acromegaly. | journal=QJM | year= 2016 | volume= | issue= | pages= | pmid=26873451 | doi=10.1093/qjmed/hcw004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26873451 }} </ref> | ||
*Insulin growth factor 1 (IGF-1) inhibits the secretion of growth hormone in two ways. IGF-1 inhibits directly the somatotroph cells or stimulates secretion the somatostatin that inhibits the GH secretion. | *Insulin growth factor 1 (IGF-1) inhibits the secretion of growth hormone in two ways. IGF-1 inhibits directly the somatotroph cells or stimulates secretion the somatostatin that inhibits the GH secretion. | ||
Revision as of 15:37, 8 August 2017
|
Acromegaly Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acromegaly pathophysiology On the Web |
|
American Roentgen Ray Society Images of Acromegaly pathophysiology |
|
Risk calculators and risk factors for Acromegaly pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Pathophysiology
Pathogenesis
- It is thought that acromegaly caused by GH secreting pituitary adenomas either microadenomas or macroadenomas.
- Normally, the growth hormone is secreted and stored in the anterior pituitary gland particularly in the somatotroph cells. Growth hormone secretion is affected by several factors. Growth hormone is stimulated by ghrelin and growth hormone releasing hormone. Somatostatin inhibits the growth hormone secretion.[1]
- Insulin growth factor 1 (IGF-1) inhibits the secretion of growth hormone in two ways. IGF-1 inhibits directly the somatotroph cells or stimulates secretion the somatostatin that inhibits the GH secretion.
- Growth hormone is functioning through binding to its receptor which is a glycoprotein receptor. Binding of GH to its receptor stimulates proteins which start a process called signal transduction and transcription. Signal transduction and transcription (STAT) induces production of IGF-1 from liver, bone and pituitary gland.[2]
- The IGF-1 is responsible for the acral features of acromegaly. IGF-1 causes the rapid increase in the hand and feet size, forehead protrusion, and jaw prominence.
- The high level of IGF-1 is responsible for the following pathologic processes:
- IGF-1 is responsible for the diabetes mellitus which is common in 20% of patients with acromegaly. IGF-1 interferes with insulin on its receptor which leads to insulin resistance and glucose elevation.
- IGF-1 causes hypertrophy of the body organs like the heart (cardiomegaly) and tongue (macroglossia).
Genetics
- [Disease name] is transmitted in [mode of genetic transmission] pattern.
- Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
- The development of [disease name] is the result of multiple genetic mutations.
Associated Conditions
Patients with acromegaly may be associated with the following conditions:[3]
- Diabetes mellitus
- Obstructive sleep apnea
- Carpal tunnel syndrome
- Hypertension
- Osteoarthritis
References
- ↑ Dineen R, Stewart PM, Sherlock M (2016). "Acromegaly". QJM. doi:10.1093/qjmed/hcw004. PMID 26873451.
- ↑ Melmed S (2009). "Acromegaly pathogenesis and treatment". J Clin Invest. 119 (11): 3189–202. doi:10.1172/JCI39375. PMC 2769196. PMID 19884662.
- ↑ Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A; et al. (2014). "Acromegaly: an endocrine society clinical practice guideline". J Clin Endocrinol Metab. 99 (11): 3933–51. doi:10.1210/jc.2014-2700. PMID 25356808.